Literature DB >> 11370519

Motor end-plates in regenerating rat skeletal muscle exposed to botulinum toxin.

I Jirmanová1, S Thesleff.   

Abstract

Botulinum toxin type A, when applied to the extensor digitorum longus muscle of rats, reduces spontaneous and evoked transmitter release to a few per cent of the normal level. The toxin, however, fails to affect the morphological redifferentiation of the postsynaptic part of the neuromuscular junction following muscle degeneration-regeneration induced by a selective myotoxic agent, bupivacaine. This indicates that neither transmitter release nor resulting muscle activity are necessary for the differentiation of the sole plate.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 11370519     DOI: 10.1016/0306-4522(76)90062-2

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  5 in total

1.  Function Suggests Nano-Structure: Quantitative Structural Support for SNARE-Mediated Pore Formation.

Authors:  Ilan Hammel; Isaac Meilijson
Journal:  Neurotox Res       Date:  2015-09-25       Impact factor: 3.911

2.  Changes in motor nerve terminals during bupivacaine-induced postsynaptic deprivation.

Authors:  J Tomas i Ferré; R Fenoll i Brunet; M Santafé; E Mayayo
Journal:  J Anat       Date:  1989-02       Impact factor: 2.610

3.  Effects of botulinum toxin induced muscle paralysis on endocytosis and lysosomal enzyme activities in mouse skeletal muscle.

Authors:  S Tågerud; R Libelius; S Thesleff
Journal:  Pflugers Arch       Date:  1986-09       Impact factor: 3.657

4.  Effect of castration and testosterone administration on the neuromuscular junction in the levator ani muscle of the rat.

Authors:  V Hanzlíková; E Gutmann
Journal:  Cell Tissue Res       Date:  1978-05-18       Impact factor: 5.249

5.  Acetylcholine receptors in regenerating muscle accumulate at original synaptic sites in the absence of the nerve.

Authors:  S J Burden; P B Sargent; U J McMahan
Journal:  J Cell Biol       Date:  1979-08       Impact factor: 10.539

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.